Science Explorer Interactive view Map
Company · Milan · Italy

CTI BioPharma (Italy)

ctibiopharma.comROR OpenAlex
World rank, all time
#14,666
of 42,892
Rank in Italy
#441
of 969
Research works
236
▲ 111% vs 2013–17
Citations
8.4k
35.6 per fractional work
Top-10% rate
12.7%
record average 16.5%
Open access
39%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.44× its world share, 13 worksBiochemistry, Geneti…Immunology and Microbiology: 6.19× its world share, 3 worksImmunology and Micro…Neuroscience: 0.70× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.41× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.15× its world share, 1 worksChemistryComputer Science: 0.51× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.16× its world share, 0 worksEarth and Planetary …Engineering: 0.26× its world share, 2 worksEngineeringEnvironmental Science: 0.42× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.42× its world share, 1 worksMaterials ScienceMathematics: 0.31× its world share, 0 worksMathematicsDentistry: 1.53× its world share, 0 worksDentistryMedicine: 2.11× its world share, 18 worksMedicineBusiness, Management and Accounting: 0.72× its world share, 1 worksBusiness, Management…Decision Sciences: 0.84× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.85× its world share, 1 worksEconomics, Econometr…Psychology: 0.20× its world share, 0 worksPsychologySocial Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.2×. Every wedge is a field page.

Which keywords describe research at CTI BioPharma (Italy)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Immunotherapy, Biopharmaceuticals, Recombinant Proteins, Immunogenicity and Protein Aggregation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 39 words, with their numbers
  1. Monoclonal Antibodies5▲ 123×3 topics
  2. Therapeutic Antibodies5▲ 147×2 topics
  3. Glycosylation4▲ 75×3 topics
  4. Immunotherapy4▲ 11×8 topics
  5. Biopharmaceuticals3▲ 139×3 topics
  6. Epidemiology3▲ 1.66×29 topics
  7. Inflammation3▲ 3.2×22 topics
  8. Recombinant Proteins3▲ 204×2 topics
  9. Immunogenicity3▲ 140×2 topics
  10. Protein Aggregation2▲ 106×2 topics
  11. Chromatography2▲ 353×1 topic
  12. Gene Therapy2▲ 28×3 topics
  13. Stability2▲ 23×1 topic
  14. Cancer Immunotherapy2▲ 33×2 topics
  15. Antibody Engineering2▲ 91×1 topic
  16. Cancer2▲ 3.7×18 topics
  17. Fc Receptors2▲ 91×1 topic
  18. Lymphoma2▲ 29×3 topics
  19. Leukemia2▲ 52×2 topics
  20. CAR T Cells2▲ 56×1 topic
  21. Chimeric Antigen Receptor2▲ 56×1 topic
  22. Immunity2▲ 8.4×4 topics
  23. Innovation2▲ 3.2×3 topics
  24. Monoclonal Antibody2▲ 64×2 topics
  25. Cell Culture1▲ 27×2 topics
  26. Risk Factors1▲ 2.8×3 topics
  27. Mammalian Cells1▲ 120×1 topic
  28. Neurodegeneration1▲ 9.5×2 topics
  29. Recombinant Protein1▲ 120×1 topic
  30. Chemotherapy1▲ 3.7×7 topics
  31. Genome Engineering1▲ 42×1 topic
  32. Glaucoma1▲ 18×1 topic
  33. Intraocular Pressure1▲ 31×1 topic
  34. RNA-Guided1▲ 42×1 topic
  35. Vaccine1▲ 6.3×4 topics
  36. Intellectual Property Rights1▲ 29×1 topic
  37. Patent Analysis1▲ 169×1 topic
  38. RNA Interference1▲ 26×1 topic
  39. siRNA Delivery1▲ 38×1 topic

Which research topics does CTI BioPharma (Italy) publish most on?

By volume in 2022–2025: Protein purification and stability, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research and Viral Infectious Diseases and Gene Expression in Insects.

Protein purification and stability: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksViral Infectious Disease…1Viral Infectious Diseases and Gene Expression in Insects: 1 fractional worksCRISPR and Genetic Engineering: 1 fractional worksGlaucoma and retinal disorders: 1 fractional worksIntellectual Property an…1Intellectual Property and Patents: 1 fractional worksRNA Interference and Gene Delivery: 1 fractional worksVirus-based gene therapy research: 1 fractional worksPancreatic and Hepatic Oncology Research: 1 fractional works
Molecular BiologyRadiology, Nuclear Medicine and ImagingOncologyOphthalmology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein purification and stability Molecular Biology 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 CAR-T cell therapy research Oncology 2 works
  4. 4 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  5. 5 CRISPR and Genetic Engineering Molecular Biology 1 works
  6. 6 Glaucoma and retinal disorders Ophthalmology 1 works
  7. 7 Intellectual Property and Patents Management of Technology and Innovation 1 works
  8. 8 RNA Interference and Gene Delivery Molecular Biology 1 works
  9. 9 Virus-based gene therapy research Genetics 1 works
  10. 10 Pancreatic and Hepatic Oncology Research Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.3%not open60.7%

World: 28% of research is openly available.

with international co-authors52.3%domestic only47.7%

World: 19% is written across borders.

How has CTI BioPharma (Italy)'s research output changed?

Output in 2018–2022 was 111% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Milan

All research institutions in Milan

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.